Zobrazeno 1 - 10
of 75
pro vyhledávání: '"V Pfister"'
Autor:
LG Brito, MGM Moura, BS Sabioni, SAB Brasil, C Arrais, V Pfister, RC Samico, VV Santos, R Schaffel
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S299- (2024)
Introdução: O Linfoma da Célula do Manto (LCM) é uma doença rara e de mau prognóstico, sendo necessário várias linhas de tratamento. Muitos tratamentos são inacessíveis aos pacientes do SUS. Avaliar a evolução dos pacientes com LCM permit
Externí odkaz:
https://doaj.org/article/6739ad0d0c74462c917ce50cbe3f8ecf
Autor:
FM Marques, V Pfister, LLM Perobelli, V Buccheri, M Yamamoto, R Santucci, SC Fortier, CS Chiattone, MV Gonçalves, C Arrais-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S329- (2024)
Introduction: In 2008, the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) established criteria for treatment indications. The Brazilian CLL Group (GBLLC) has been evaluating a more conservative approach in the indication and initiatio
Externí odkaz:
https://doaj.org/article/b15a77cd9f834108a0e4658d23feb339
Autor:
V Pfister, FM Marques, R Santucci, V Buccheri, G Ribeiro, VLP Figueiredo, N Hamerschlak, A Costa, T Silveira, A Scheliga, L Perobelli, CS Chiattone, C Arrais-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S327-S328 (2024)
Introduction: Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, is associated with increased survival and prolonged response, even in high-risk scenarios, with relatively low toxicity compared to chemoimmunotherapy. However, a significant number
Externí odkaz:
https://doaj.org/article/ed19c137f5f24762bd10e68c250f08cc
Autor:
AP Tavares, FM Marques, MC Seiwald, ACK Vieira, L Perobelli, PA Fernandes, V Pfister, VC Molla, MV Gonçalves, C Arrais-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S335-S336 (2024)
Introdução: A tricoleucemia (hairy cell leukemia - HCL) é uma neoplasia hematológica rara que corresponde a menos de 2% de todas as leucemias, com estimativa de 1100 novos casos diagnosticados por ano nos EUA. A incidência é maior em pacientes
Externí odkaz:
https://doaj.org/article/33cfef10ed7b4da0a78dbcf20c64df03
Autor:
LL Perruso, A Costa, WF Silva, FR Mendes, V Pfister, RS Siquieroli, J Martins, C Chiattone, M Nascimento, ER Mattos, MDH Perico, YS Rabelo, EM Rego
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S436-S437 (2024)
The Brazilian Acute Myeloid Leukemia Registry (RBLMA) is a recent initiative aimed at determining the clinical and epidemiological aspects of acute myeloid leukemia (AML) in Brazil. The full comprehension of our epidemiology and clinical outcomes are
Externí odkaz:
https://doaj.org/article/ef690f14ea824405a02c7473a9000738
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S176- (2023)
Introduction: Venetoclax has demonstrated substantial efficacy in the treatment of chronic lymphocytic leukemia (CLL). However, the metabolism of venetoclax primarily relies on the cytochrome P450 enzyme CYP3A4, which can be influenced by concurrent
Externí odkaz:
https://doaj.org/article/d80318ab04224fe88fa8939e61a7e866
Autor:
FM Marques, V Pfister, LLM Perobelli, V Buccheri, R Santucci, GN Ribeiro, N Hamerschlak, MV Gonçalves, CS Chiattone, C Arrai-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S176-S177 (2023)
Introduction: Chronic lymphocytic leukemia (CLL) exhibits diverse treatment requirements, with some patients receiving immediate treatment while others remain under observation. In 2008, the International Workshop on Chronic Lymphocytic Leukemia (IWC
Externí odkaz:
https://doaj.org/article/4508b080968547b58bbdfeb12e0306ec
Autor:
FM Marques, V Pfister, LLM Perobelli, R Santucci, V Buccheri, TB Soares, A Azevedo, MV Gonçalves, CS Chiattone, C Arrais-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S117-S118 (2021)
Objective: To describe the outcomes of different reasons for initiating first-line treatment in a series of patients with CLL. Methods: Retrospective observational study with all patients with CLL in the Brazilian Registry of CLL(RBCLL), that was sta
Externí odkaz:
https://doaj.org/article/abf8de7b0e87473a8565a0889ab032ff
Autor:
F.M. Marques, V. Pfister, R. Santucci, V.C. Molla, Y. Novis, T.M.B. Silveira, M.V. Gonçalves, V. Buccheri, C.S. Chiattone, C. Arrais-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 103-104 (2020)
Externí odkaz:
https://doaj.org/article/da02127683b44aa58545cec798d15cb7
Autor:
V. Pfister, F.M. Marques, R. Santucci, V. Buccheri, A. Azevedo, T.M.B. Silveira, L. Fogliato, L. Perobelli, C.S. Chiattone, C. Arrais-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 101-102 (2020)
Externí odkaz:
https://doaj.org/article/93ec9f1847724e3a8a5fac45bb385c26